Want to see HHS full AI Analyst Report?
Harte-Hanks (HHS) AI Stock Analysis
Top Page
Harte-Hanks
(NASDAQ:HHS)
The score is held down primarily by weak financial performance (sharp revenue contraction, losses, elevated leverage, and negative free cash flow). Technicals are supportive but look overextended (overbought signals), which tempers the momentum benefit. The announced acquisition at $5.00 per share is a significant positive catalyst, partially offsetting fundamentals, while valuation is hard to assess due to negative earnings and no dividend data.
Harte-Hanks (HHS) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $28.85M
- Dividend Yield
- ―
- Average Volume (3M)
- 173.67K
- Price to Earnings (P/E)
- -5.1
- Beta (1Y)
- 0.81
- Revenue Growth
- -11.62%
- EPS Growth
- -87.59%
- Country
- US
- Employees
- 1,719
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Specialty Business Services
Harte-Hanks Business Overview & Revenue Model
Company Description
Harte Hanks, Inc. is an established global firm specializing in customer experience solutions, operating both domestically and internationally. Its business is structured around three primary divisions: Marketing Services, Customer Care, and Fulfillm...
How the Company Makes Money
Harte Hanks primarily makes money by providing marketing and customer experience services to business clients under service contracts and project-based engagements. Key revenue streams generally include: (1) Marketing services fees for planning, crea...
Harte-Hanks Earnings Call Summary
The earnings call reflects a mixed outlook for Harte Hanks. While there are positive developments in revenue growth, new client acquisitions, and cost-saving initiatives, these are offset by declines in certain segments, reduced operating income and EBITDA, and challenges with cash flow and pension costs. The company is focusing on long-term strategies and acknowledges short-term fluctuations.
Q3-2024 Updates
Positive Updates
Negative Updates
Company Guidance
During the Harte Hanks Third Quarter 2024 Earnings Call, management provided detailed guidance on the company's performance and strategic direction. Kirk Davis, CEO, reported a modest 1.1% year-over-year revenue increase, contrasting the negative 16.6% decline from Q3 2023 when adjusted for acquired revenue. He acknowledged the expectation of a low to mid-single digit revenue decline in Q4, citing natural fluctuations in their growth trajectory. The focus remains on optimizing free cash flow, with significant investments in the newly established Customer Excellence and Growth division. David Garrison, CFO, highlighted the $47.6 million in revenues for Q3 2024, driven by growth in Customer Care and Sales Services, despite declines in other segments. The company aims for a $6 million EBITDA improvement, facilitated by Project Elevate's cost-saving measures, including personnel optimization and streamlined operations. Financially, the company ended the quarter with $5.9 million in cash and no debt, after a strategic $6.1 million contribution to terminate Pension Plan 1.
Harte-Hanks Financial Statement Overview
Summary
Financial quality is weak-to-below average. The income statement shows a sharp TTM revenue decline (~41.7%) with operating and net losses (net margin ~-3.7%). Leverage is elevated relative to the current earnings profile (debt-to-equity ~1.57) with negative ROE (~-30%). Cash flow is pressured and volatile, with slightly positive TTM operating cash flow but negative free cash flow, increasing liquidity/execution risk until sales and profitability stabilize.
Income Statement
24NegativeBalance Sheet
43NeutralCash Flow
32Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 154.63M | 159.57M | 185.24M | 191.49M | 206.28M | 194.60M |
| Gross Profit | 35.13M | 109.67M | 128.60M | 131.92M | 140.58M | 144.33M |
| EBITDA | -1.03M | 3.46M | 12.05M | 13.28M | 22.48M | 19.72M |
| Net Income | -5.71M | -811.00K | -30.30M | -1.57M | 36.78M | 14.97M |
Balance Sheet | ||||||
| Total Assets | 88.06M | 91.83M | 101.78M | 131.07M | 119.98M | 107.86M |
| Cash, Cash Equivalents and Short-Term Investments | 5.18M | 5.59M | 9.93M | 18.36M | 10.36M | 11.91M |
| Total Debt | 24.04M | 22.40M | 24.60M | 28.51M | 22.32M | 30.77M |
| Total Liabilities | 72.71M | 71.30M | 80.09M | 111.22M | 101.18M | 122.85M |
| Stockholders Equity | 15.35M | 20.53M | 21.69M | 19.86M | 18.81M | -14.99M |
Cash Flow | ||||||
| Free Cash Flow | -1.43M | -4.49M | -6.73M | 7.67M | 22.99M | -4.81M |
| Operating Cash Flow | 1.30M | -1.74M | -2.99M | 10.48M | 28.79M | -1.76M |
| Investing Cash Flow | -2.73M | -2.76M | -3.74M | -2.31M | -11.49M | -2.90M |
| Financing Cash Flow | 2.68M | 514.00K | -419.00K | -3.22M | -15.82M | -13.41M |
Harte-Hanks Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HHS, the sentiment is Negative. The current price of 3.87 is below the 20-day moving average (MA) of 4.19, below the 50-day MA of 4.30, and above the 200-day MA of 3.08, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 36.75 is Neutral, neither overbought nor oversold. The STOCH value of 48.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HHS.
Harte-Hanks Risk Analysis
Harte-Hanks disclosed 30 risk factors in its most recent earnings report. Harte-Hanks reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksHarte-Hanks Peers Comparison
Overall Rating
DLX66Neutral
HHS51Neutral
MCHX47Neutral
SWAG46Neutral
FLNT32Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 66Neutral | $1.04B | 9.99 | 14.63% | 5.31% | 0.30% | 71.14% | |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| 51Neutral | $28.85M | -5.06 | -30.13% | ― | -11.62% | -87.59% | |
| 47Neutral | $63.85M | -11.43 | -18.24% | ― | -7.47% | -16.48% | |
| 46Neutral | $24.23M | 590.91 | 0.18% | ― | 10.26% | ― | |
| 32Underperform | $108.73M | -4.47 | -151.70% | ― | -12.05% | 43.57% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HHS | Harte-Hanks, Inc. | 3.87 | 0.86 | 28.57% | |
| DLX | Deluxe Corp. | 22.59 | 5.40 | 31.40% | |
| MCHX | Marchex | 1.44 | -0.33 | -18.87% | |
| FLNT | Fluent Inc | 3.44 | 1.35 | 64.59% | |
| BAOS | Baosheng Media Group Holdings Ltd | 0.15 | -2.86 | -95.02% | |
| SWAG | Stran & Company, Inc | 1.30 | -0.64 | -32.99% |
Harte-Hanks Corporate Events
Harte Hanks Reaffirms Merger Path With Star Equity
NeutralOn September 15, 2026, Harte Hanks announced that the Go-Shop Period under its August 14, 2026 merger agreement with Star Equity Holdings had expired, following active solicitation of 93 potential bidders and the receipt of acquisition proposals. The...
Harte Hanks to Be Acquired by Star Equity Holdings
PositiveOn August 14, 2026, Harte Hanks agreed to be acquired by Star Equity Holdings in a definitive merger valuing the company at $5.00 per share, or about $38.4 million in equity value. Shareholders unanimously backed the deal, which offers either cash or...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 19, 2026